Arteriocyte to start stem cell study for artery obstruction
This article was originally published in Clinica
Executive Summary
Stem cell specialist Arteriocyte Medical Systems has received approval from the US FDA to start a Phase I safety study of its Magellan MAR01 device in critical limb ischaemia (CLI).